Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company is headquartered in Toronto, Canada.
| Revenue (TTM) | $1.14M |
| Gross Profit (TTM) | 645,000 |
| EBITDA | $-8.46M |
| Operating Margin | -583.00% |
| Return on Equity | -548.00% |
| Return on Assets | -70.90% |
| Revenue/Share (TTM) | $0.09 |
| Book Value | $0.55 |
| Price-to-Book | 4.36 |
| Price-to-Sales (TTM) | 28.48 |
| EV/Revenue | 28.19 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 677.00% |
| Shares Outstanding | $15.71M |
| Float | $12.82M |
| % Insiders | 25.36% |
| % Institutions | 6.34% |